Breaking News Instant updates and real-time market news.

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

08:33
11/21/18
11/21
08:33
11/21/18
08:33

Verily collaboration more favorable to DexCom after revision, says Stephens

Stephens analyst Chris Cooley said DexCom's (DXCM) revised agreement with Alphabet's (GOOGL) Verily makes DexCom the preferred CGM partner while also replacing the former royalty agreement with an enhanced equity stake. The revised pact "solidifies the long-term potential of the collaboration while setting-up a more favorable EBITDA profile" for DexCom, contends Cooley, who keeps an Overweight rating and $170 price target on DexCom shares.

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

DXCM DexCom
$119.89

-1.34 (-1.11%)

11/07/18
JEFF
11/07/18
NO CHANGE
Target $148
JEFF
Buy
DexCom price target raised to $148 from $125 at Jefferies
Jefferies analyst Raj Denhoy raised his price target for DexCom (DXCM) to $148 saying the company posted "strong" Q3 results. Improving market access from pharmacy benefit is driving patient adds and helping blunt any advantage for Abbott's (ABT) Libre, says the analyst. He keeps a Buy rating on DexCom citing strong G6 adoption, new patients accelerating and still underpenetrated markets.
11/12/18
PIPR
11/12/18
NO CHANGE
PIPR
Piper continues to like pure play diabetes stocks after conference
Piper Jaffray analyst JP McKim left this weekend's Diabetes Technology Meeting feeling that DexCom (DXCM) "has a lot in its pipeline" and remains a few steps ahead of the competition, Insulet (PODD) is having "great success" in the pharmacy and is on the forefront of cybersecurity, and Tandem Diabetes (TNDM) remains in a "strong position to take market share." The analyst continues to like pure play diabetes names and keeps an Overweight rating on all three names.
11/21/18
PIPR
11/21/18
NO CHANGE
Target $157
PIPR
Overweight
Amended Verily agreement 'major win' for DexCom holders, says Piper Jaffray
After talking with management, Piper Jaffray analyst JP McKim believes the amended collaboration and license agreement with Alphabet's (GOOG, GOOGL) Verily "seems like a no brainer" and is a "major win for the long term value" of DexCom (DXCM) shareholders. The royalty payments from the original agreement have been eliminated and those would have been at least a 500 basis point headwind on the margin profile of DexCom's business, McKim tells investors in a research note. He expects the company to release some longer term margin targets at its analyst day and says "removing this future headwind is a major win." Further, DexCom is now the preferred continuous glucose monitoring supplier into Onduo's Type 2 diabetes management program, says the analyst. He reiterates an Overweight rating on the shares with a $157 price target.
11/21/18
WBLR
11/21/18
NO CHANGE
WBLR
Outperform
Amended Verily agreement a win for DexCom, says William Blair
William Blair analyst Margaret Kaczor views the amendment to its collaboration agreement with Verily as a financial and strategic win for DexCom. The new deal should strengthen their partnership and "meaningfully improve" Dexcom's future profitability, Kaczor tells investors in a research note. Overall, despite the near-term dilution, the amended agreement is a positive step for the company that should give it more control over the launch prospects of its next-generation devices and flexibility over commercial strategies in the type 2 patient population, says the analyst. She keeps an Outperform rating on shares of DexCom.
GOOG Alphabet
$1,026.00

7 (0.69%)

11/14/18
LEHM
11/14/18
NO CHANGE
Target $1400
LEHM
Overweight
Barclays removes Alphabet as Top Pick, keeps Overweight rating
Barclays analyst Ross Sandler removed Alphabet (GOOGL) as his Top Pick and did not replace it with another stock. The analyst, however, keeps an Overweight rating on the shares with a $1,400 price target.
11/15/18
MSCO
11/15/18
NO CHANGE
MSCO
Morgan Stanley highlights four tech stocks to buy following recent pullback
Morgan Stanley analysts Katy Huberty, Keith Weiss, Brian Nowak, Joe Moore, James Faucette and Brian Essex collaborated on a report addressing technology stocks following the recent market pullback, contending the fact that technology sector concentration remains near all-time highs suggests that its "probably too early" to buy the sector broadly. However, they highlight four stocks - Alphabet (GOOGL), Take-Two Interactive (TTWO), Microsoft (MSFT) and Xilinx (XLNX) - for which they believe the pullback is not fundamentally driven and the companies have strong secular tailwinds. The firm's analyst call these four stocks their "highest conviction" names and maintain Overweight ratings on all four.
11/19/18
JMPS
11/19/18
NO CHANGE
Target $1375
JMPS
Outperform
JMP says former Oracle exec well positioned to keep scaling Google Cloud
Following Google's announcement last week that Google Cloud CEO Diane Greene is stepping down in January and being replaced in that role by Thomas Kurian, who most recently served as President of Product Development at Oracle (ORCL), JMP Securities analyst Ronald Josey said he was somewhat surprised but believes Kurian is well positioned to continue scaling Google Cloud and growing its sales force. Josey maintains an Outperform rating and $1,375 price target on shares of Google parent Alphabet (GOOGL).
GOOGL Alphabet Class A
$1,031.22

4.99 (0.49%)

TODAY'S FREE FLY STORIES

SHW

Sherwin-Williams

$385.73

-0.075 (-0.02%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Upgrade
Sherwin-Williams rating change  »

Sherwin-Williams upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.12

0.035 (1.14%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Achillion to hold a conference call »

Dr. Stephen Zelenkofske,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

MDP

Meredith

$53.26

-0.54 (-1.00%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Meredith management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

EQH

AXA Equitable

$16.87

-0.67 (-3.82%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AXA Equitable to hold a conference call »

Investor Conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AEYE

AudioEye

$6.99

-0.09 (-1.27%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AudioEye management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

TLRA

Telaria

$2.81

-0.02 (-0.71%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

CSCO

Cisco

$45.80

-1.66 (-3.50%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
UBS to host a conference call with Cisco »

UBS IT Hardware Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 10

    Jan

  • 04

    Mar

MGPI

MGP Ingredients

$56.54

0.05 (0.09%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
MGP Ingredients management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

EFX

Equifax

$97.19

0.07 (0.07%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Equifax to meet with investors »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Housing Market Index to be reported at 10:00 »

December Housing Market…

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

VNDA

Vanda Pharmaceuticals

$26.26

0.11 (0.42%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Biotech Analyst Duncan,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

CSTM

Constellium

$7.71

-0.7 (-8.32%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Constellium management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

EXC

Exelon

$47.07

0.11 (0.23%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Exelon management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

GNRC

Generac

$52.13

-1.39 (-2.60%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Generac management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

IPGP

IPG Photonics

$117.95

-2.28 (-1.90%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
IPG Photonics management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Empire State Mfg Survey General Business Conditions Index to be reported at 08:30 »

December Empire State Mfg…

04:55
12/17/18
12/17
04:55
12/17/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

LPSN

LivePerson

$19.21

-0.785 (-3.93%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
LivePerson management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

SMLR

Semler Scientific

$0.00

(0.00%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Semler Scientific management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 07

    Jan

LPTX

Leap Therapeutics

$2.92

0.07 (2.46%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Leap Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

ATNX

Athenex

$11.97

-0.59 (-4.70%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Athenex to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

IMMY

Imprimis

$5.80

-0.12 (-2.03%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Imprimis management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

ST

Sensata

$42.73

-1.07 (-2.44%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Sensata management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.